SecBot SecBot
8-K ·Filed Nov 9, 2026

NOVT

NOVANTA INC
BULLISH
Impact 6/10
Horizonweeks Processed7d 8h ago SEC0001193125-26-453760
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

Watch Q4 2026 guidance for adjusted EPS growth of only 0-5% YoY despite 18%+ revenue growth, suggesting margin headwinds from acquisition integration and higher interest expense. Monitor the Riverpoint Medical milestone payment and leverage trajectory.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$123.71
T+0 close · Nov 9, 2026 · via day close
Latest settled
−0.32%
T+1 · $123.31 · next T+5 in 5h
Vs SPY
−1.64%
α at T+1
Latest observation
−3.54%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $123.71entry
  2. T+1 · 6d ago −0.32%α −1.64% · $123.31
  3. T+4 · todayOpen
  4. T+5 · in 5h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Novanta reported Q3 2026 revenue of $305M (+23.1% YoY, +9.9% organic) and adjusted EPS of $1.05 (+20.7% YoY), both above consensus estimates of $301M and $0.97. The company raised full-year 2026 revenue guidance to $1,135M-$1,140M and adjusted EPS to $3.66-$3.71, reflecting strong momentum from the Riverpoint Medical acquisition and organic growth.

Key Financial Metrics

EPS (Adj.)
$1.05
est $0.97 · +8.3% · GAAP: $0.05
Revenue
$305.0M
est $301.0M · +1.3% · +23.1% YoY
Rating
beat
Guidance
$1,135M-$1,140M
raised
Free Cash Flow
$31.5M
Gross Margin
44.5%

Key Facts

  • Q3 2026 GAAP revenue $305M, up 23.1% YoY; organic revenue growth 9.9%
  • Adjusted diluted EPS $1.05, up 20.7% YoY vs consensus $0.97 (beat)
  • Adjusted EBITDA $80.3M, up 38.3% YoY; margin expanded 290 bps to 26.3%
  • Customer bookings increased 29% YoY; backlog grew to $543M
  • Full-year 2026 revenue guidance raised to $1,135M-$1,140M (prior $1,040M-$1,055M)
  • Full-year 2026 adjusted EPS guidance raised to $3.66-$3.71 (prior $3.50-$3.65)
  • Closed largest acquisition in company history (Riverpoint Medical) during Q3
  • Net debt increased to $689M from net cash position of $121M at year-end 2025 due to acquisition financing

Financial Impact

Revenue beat consensus by $4M (1.3%); adjusted EPS beat consensus by $0.08 (8.2%); full-year guidance raised by ~$80M revenue and ~$0.11 EPS at midpoint

revenueadjusted EPSadjusted EBITDAbacklogguidance

Segment Breakdown

SegmentRevenueGrowth
Automation Enabling Technologies$145.4M+16.0%
Medical Solutions$159.7M+30.3%

Risk Factors

  • Net debt surged to $689M from a net cash position, increasing financial leverage and interest expense
  • GAAP net income fell to $2M from $10.7M due to $23M in restructuring and acquisition costs
  • Q4 adjusted EPS guidance of $0.91-$0.96 implies 0-5% YoY growth, a sharp deceleration from Q3's 21% growth
  • Integration risk from the largest acquisition in company history

Market Snapshot

Exchange
Nasdaq
Sector
Miscellaneous Electrical Machinery, Equipment & Supplies
Analyst Consensus
80% bullish (10 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-453760
Document: novt-20261109.htm0001193125-26-453760
Document: 0001193125-26-453760-index-headers.html0001193125-26-453760
Document: 0001193125-26-453760-index.html0001193125-26-453760
Document: 0001193125-26-453760.txt0001193125-26-453760
8-K Data (Synthetic)0001193125-26-453760

Track record

3 reports on NOVT

Performance horizon
Filters
  1. Nov 9, 20267d ago 8-K Bullish 6/10 Viewing Entry $123.71 to $123.31 Now $114.40 −7.53% ▼ −0.32% −1.64% vs SPY
  2. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $145.76 to $146.24 Now $114.40 −21.51% ▲ +0.33% +0.81% vs SPY
  3. Jun 29, 202620w ago S-3ASR Neutral 4/10 Entry $162.24 to $163.70 Now $114.40 −29.49% ▲ +0.90% +1.04% vs SPY
Showing 3 of 3

US Market Status

Market Closed · Opens in 7h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026